Latest News

The Food and Drug Administration in the USA has accepted Vivus’s new drug application for the approval of their obesity drug, Qnexa, which will assist with weight loss in obese patients with a BMI of greater than 30 or patients who are overweight with a BMI of greater than 27 and with other health c...

A recent study carried out by Bayer Healthcare has highlighted the growing number of women who take risks when having sexual intercourse by not thinking about contraception...

Men who experience erectile dysfunction as a result of clogged arteries leading to the penis may soon have another option for treatment beyond the oral and urethral medications available which do not work for every man...

The latest smoking cessation product to be trialled is Tabex (cytisine) and it has shown some promise according to recent research carried out at UCL and the UK Centre for Tobacco Control using 740 participants who were treated with the drug or a placebo for 25 days...

The Food and Drug Administration have announced that it has given Eli Lily’s successful erectile dysfunction drug, Cialis, the go ahead for the treating of enlarged prostate, benign prostatic hyperplasia, BPH, and with men who suffer from erectile dysfunction, they will experience double the benefit...